Stocktoria

PHIBRO ANIMAL HEALTH CORP PAHC

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2014-04-11 · LEI

PHIBRO ANIMAL HEALTH CORP statistics & valuation

P / E12.9×
P / S0.8×
P / B3.3×
Net margin6.6%
Return on capital16.4%
Graham number -34.2%$22.68

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($22.68); a green figure means the price is below it.

Profitability & efficiency

Net margin (%)
8.50% 7.90% 6.60% 4.20% 6.50% 5.20% 3.30% 0.20% 3.70% 6.60% 2017201820192020202120222023202420252026
Gross margin (%)
32.50% 32.50% 32.00% 32.10% 32.60% 30.30% 30.50% 30.80% 30.90% 33.80% 2017201820192020202120222023202420252026
Operating margin (%)
12.80% 12.10% 10.10% 8.60% 9.00% 8.40% 7.30% 5.20% 8.50% 12.80% 2017201820192020202120222023202420252026
Return on equity (%)
42.70% 35.10% 25.30% 17.80% 22.80% 18.70% 11.50% 0.90% 16.90% 25.90% 2017201820192020202120222023202420252026
Shares outstanding
40042 40385 40523 40.5M 40.5M 40.5M 40.5M 40.5M 40.7M 41.0M 2017201820192020202120222023202420252026
Net debt ($)
$213.7M $292.6M $241.5M $563.6M 2017201820192020202120222023202420252026
Share buybacks ($)
2017201820192020202120222023202420252026
Return on assets (%)
10.40% 9.70% 7.50% 4.30% 6.50% 5.30% 3.40% 0.20% 3.50% 6.60% 2017201820192020202120222023202420252026
Free cash flow margin (%)
2017201820192020202120222023202420252026
Debt / equity (×)
1.10× 1.18× 1.22× 2.21× 2017201820192020202120222023202420252026
EPS ($)
$1.61 $1.61 $1.35 $0.83 $1.34 $1.21 $0.81 $0.06 $1.19 $2.43 2017201820192020202120222023202420252026

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

P / E vs its own history

PHIBRO ANIMAL HEALTH CORP trades at about 14.2× earnings — below its 10-year norm (10-year range 15×–314.7×, median 23.1×).

14.2× 314.7×

Shaded band = 10-year range (15×–314.7×); dot = today's 14.2×.

Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.

Key ratios (by fiscal year)

RatioFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Gross margin33.8%30.9%30.8%30.5%30.3%32.6%32.1%32.0%32.5%32.5%
Operating margin12.8%8.5%5.2%7.3%8.4%9.0%8.6%10.1%12.1%12.8%
Net margin6.6%3.7%0.2%3.3%5.2%6.5%4.2%6.6%7.9%8.5%
Return on assets6.6%3.5%0.2%3.4%5.3%6.5%4.3%7.5%9.7%10.4%
Return on equity25.9%16.9%0.9%11.5%18.7%22.8%17.8%25.3%35.1%42.7%
Debt / equity—2.21×1.22×1.18×1.10×—————
Current ratio2.962.762.943.332.973.042.873.022.903.14

Computed from company filings · US · as of 2026-06-30. Facts plus Stocktoria's own computed scores — not investment advice.